Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes. - Test2 - elhamkhani - TriplyDB

Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes.

Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes.

http://www.wikidata.org/entity/Q33526301

about

Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genes.Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer.Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex.Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.A simple and cost-effective method of DNA extraction from small formalin-fixed paraffin-embedded tissue for molecular oncologic testing Three multiplex snapshot assays for SNP genotyping in candidate innate immune genes.High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit.A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method Simultaneously Detection of 50 Mutations at 20 Sites in the BRAF and RAS Genes by Multiplexed Single-Nucleotide Primer Extension Assay Using Fine-Needle Aspirates of Thyroid Nodules Method: a single nucleotide polymorphism genotyping method for Wheat streak mosaic virus.Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Genetically informed lung cancer medicine.Detection of KRAS and BRAF mutations in advanced colorectal cancer by allele-specific single-base primer extension.The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.AmpliVar: mutation detection in high-throughput sequence from amplicon-based libraries.SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics.Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.Molecular diagnostics of a single multifocal non-small cell lung cancer case using targeted next generation sequencing.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients.Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma.

P2860

Q26799467-1DFFF4C9-DDC0-4951-B818-80ED845AA64E Q28543021-45CECB25-C20E-4B86-96F6-3718297FFF63 Q31132555-AFC7D0A7-5727-4162-A1BF-765BDFF73232 Q33716499-3E0732C8-8F36-48D1-A3A0-A847D2592233 Q33726858-41CD2F47-D3E2-4FEC-98E9-F121651FA1D7 Q33732199-B4D86F22-6081-4FFF-AED5-528DEDD1A93A Q33745140-01A6432D-EC58-403C-AC3E-5B9BF966B906 Q33790242-60E6247F-E3B4-4812-8D7F-3EB875D8E7AF Q33809458-154B529E-1A17-433F-81C0-842EBC3B35B7 Q33867475-316DB0AE-69B7-411D-9AD3-152134D4A429 Q33947516-219343AF-5ED2-4CFA-AFE9-B6367BF219A6 Q34580271-2DCB9FF6-8897-44BE-8483-F9FA73D8626A Q34645477-BEA386A0-2C30-4C72-AD44-C03550B811D2 Q34760642-8A699058-C220-4418-A0FD-0786DC27102A Q34978610-F9E64741-3752-44CF-ABC7-6B99757DC7AC Q35169256-B261E61B-52B5-4C05-BFEC-2DC90BAE8BD4 Q35187723-EC267E68-4827-4884-822D-FAD6DB364578 Q35237841-68C77CA8-F194-480F-B832-58E07B9747CF Q36074183-649034B0-5288-46C8-8621-352A07D79138 Q36302357-F6E40D89-7222-4188-8EF9-A68B07FB0A69 Q36368083-974D54AD-483E-4304-AEE0-06E2BEBF6599 Q36393095-C6BD81C5-C4C1-4B85-B147-B94D29B80970 Q37525272-2B35B6FE-577F-4E75-92CC-4F0E502DDA59 Q37815136-4E01F4DD-7479-4EE1-9CD8-7D48F0740115 Q37948845-4F136F45-FB8D-4EEA-8CA1-1E967E480069 Q38012417-39B57735-9920-44EA-84D0-A10FA8993F05 Q38545768-CB86B169-80B4-47D6-B131-22A00988EE70 Q39147481-262342ED-3FFE-4CF9-8D23-95161E4775D7 Q39739202-7FBD7E1F-001F-4CD7-A585-7674A446A9F5 Q40108385-149046A5-9355-4E12-9DA3-F971822815D9 Q41460750-3FAC25F7-CBAE-4F8E-9D01-36CD44930439 Q42075151-1411FEC9-33F5-4764-A66D-1A87FEBCB48A Q44850155-2C3C0320-EFE7-4CBD-9B0D-3B017191650A Q45753320-F9AAF0A6-01DF-4CB6-945F-89D5B7D49C3C Q47203432-BF5D787B-1194-472A-84F0-474675A2B0E5 Q52647654-7181F256-9187-4B4B-AC5A-17D6BD292363 Q53141713-7D1D06F5-F745-4F4C-A555-8F94C4992316 Q53246286-04E791A1-AF58-487A-80DD-2B293E5D7E74 Q54334205-5C47FB24-EA4C-4B01-AAF3-728764280109 Q54522784-7E9686E2-BB96-4833-B778-8D4458E923FE

P2860

Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes.

http://www.wikidata.org/entity/Q33526301

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@ast

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en-gb

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@nl

type

label

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@ast

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en-gb

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@nl

prefLabel

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@ast

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en-gb

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@nl

P1433

Q33526301-DCC0C5ED-B33C-404E-A5E9-790E7E082590

P1476

Q33526301-104CD7D9-6660-4674-8F6D-072E1957D53F

P2093

Q33526301-2E05959D-42EE-4559-9845-E80F86376716

Q33526301-77FF37A5-B823-4A4E-9C91-B86ED54A1C6D

Q33526301-7F1BABD2-1407-4180-9892-04E447E7A1DE

Q33526301-91315661-DF86-4F8E-A365-FEC6985A8054

Q33526301-DD76B616-19C4-4298-BB93-114ABAD2406B

Q33526301-FF8ECF4D-ACC4-4CFF-9EAA-ACAF17B46930

P2860

Q33526301-0A2FEADE-6BF8-4BF5-9AAB-2A162C382029

Q33526301-0DA187B6-FBFD-4C5C-AE83-815A36C75B0F

Q33526301-2046A781-3FE2-48BD-9AFF-94E8E9B2DB22

Q33526301-337CBCB1-64E5-4C23-A85C-345FEC8E267B

Q33526301-44B9AF11-6203-4438-8D0C-99D59AD8947B

Q33526301-470C86A6-9DBB-4C10-A900-9B8092BED406

Q33526301-5124EA1D-19F4-4D64-940E-7816A41151E6

Q33526301-51E8CDBA-1C16-452B-8A96-9A1FE015B602

Q33526301-565EC551-AC69-4804-BC08-16469470AC01

Q33526301-667079D7-BC44-4005-AE3B-4EBA86A5127F

P304

Q33526301-60FDE46E-A395-4D93-B6BE-965AF52014B1

P31

Q33526301-7F423836-9E29-4680-B304-AAB5D14AED8B

P356

Q33526301-65554E2D-6DC4-4605-8498-790FF7AA92F3

P407

Q33526301-3C086632-2889-4ED1-B5C9-4DFE3413951B

P433

Q33526301-55D24D9B-56F5-4E9E-8107-AEC05E2E31D0

P478

Q33526301-7237D42F-8320-4B96-A58D-A352D3005B9E

P50

Q33526301-39CD1E72-A773-4FD7-A8C7-8867FE7D48C6

P577

Q33526301-CE3EE03D-F01B-429A-BAD0-7B97D5AC4F21

P5875

Q33526301-0D3EF9A1-F64C-45E7-ABCC-4BAD105FFB67

P698

Q33526301-49652E7E-E915-4B42-9412-4506CF768826

P932

Q33526301-A3B347BB-7BB0-4ABC-A2F2-85E23748CEEC

P356

JOURNAL.PONE.0008802

P1433

P1476

Two multiplex assays that simu ...... , BRAF, NRAS and PIK3CA genes.

@en

P2093

Angela A G van Tilborg

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Carolyn D Hurst

http://www.w3.org/2001/XMLSchema#string

Ellen C Zwarthoff

http://www.w3.org/2001/XMLSchema#string

Irene Lurkin

http://www.w3.org/2001/XMLSchema#string

Robert Stoehr

http://www.w3.org/2001/XMLSchema#string

P2860

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.

Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.

PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer

KRAS mutations predict response to EGFR inhibitors.

P304

e8802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0008802

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Margaret A Knowles

P577

2010-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41124063

http://www.w3.org/2001/XMLSchema#string

P698

20098682

http://www.w3.org/2001/XMLSchema#string

P932

2809099

http://www.w3.org/2001/XMLSchema#string